Etamivan
From Wikipedia, the free encyclopedia
 |
|
| Clinical data | |
|---|---|
| Trade names | Analepticon |
| ATC code | R07AB04 (WHO) |
| Identifiers | |
|
|
| CAS Number | 304-84-7  |
| PubChem (CID) | 9363 |
| DrugBank | DB08989  |
| ChemSpider | 8996 |
| UNII | M44O63YPV9 |
| KEGG | D04080 |
| ECHA InfoCard | 100.005.599 |
| Chemical and physical data | |
| Formula | C12H17NO3 |
| Molar mass | 223.268 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Etamivan (INN, or ethamivan (USAN); trade names Analepticon and Vandid) is a respiratory stimulant drug[1] related to nikethamide. It was mainly used in the treatment of barbiturate overdose[2] and chronic obstructive pulmonary disease,[3] but has now largely fallen into disuse.
References[edit]
- ^ Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. Journal of Pharmacology and Experimental Therapeutics. 1975 May;193(2):657-63.
- ^ Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. Canadian Medical Association Journal. 1963 Jul 6;89:20-2.
- ^ Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. Canadian Medical Association Journal. 1964 Dec 5;91:1203-8.
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
